Opening Recap
Market Pulse: Tech earnings drove the tone after Oracle smashed forecasts and Domo’s surprise beat rallied sentiment despite modest top-line growth.
Key Movers: Oracle’s cloud revenue surge (Slashdot.org, SiliconANGLE News) and Domo’s 30% stock spike on earnings beat stole the show, while Marathon’s BTC shuffle had crypto traders biting nails.
Macro & Politics: No major Fed teasers leaked yesterday, but Beyond Air’s failed NeuroNOS sale underscores regulatory volatility in biotech.
What’s Next: Eyes on Fed minutes today—any hint of dovish flair could spark fresh rallies or ignite a pullback.
Market Commentary
What everyone’s missing is the ripple effect of Oracle’s announced headcount cuts after that cloud revenue surge. Sure, headlines like “Oracle Will Downsize Its Product Teams Because Of AI” (Gizmodo.com) validate the AI narrative, but under the hood, slimmer teams could choke innovation velocity—it’s a detail most gloss over.
Connect Domo’s modest revenue rally (SiliconANGLE News) with Circle’s stablecoin upside thesis (CoinDesk), and you see a market chasing beats and crypto pitches equally. It’s almost absurd to watch two unrelated beats fuel the same euphoric mood—this herd instinct might bite hard once the margin squeeze starts.
Action time: trim exposure to headline-driven pops and brace for backlash when reality bites. Consider hedges in digital assets if you’re gambling on Circle’s 60% upside or shift to value plays when earnings surprises lose their shine—stay alert and let fundamentals lead.
📈 Breaking Financial News
Oracle Stock Jumps After Earnings Beat Expectations. Why It ‘Will Not Be’ Disrupted. – Barron's
Oracle Stock Jumps After Earnings Beat Expectations. Why It ‘Will Not Be’ Disrupted.Barron's Oracle stock jumps 9% on earnings beat and increased guidance as cloud revenue climbs 44%CNBC Oracle beats Q3 expectations, raises 2027 revenue outlook sending stock …
Oracle’s cloud revenue surges 44%, easing pressure on its stock
Oracle Corp. brushed aside fears that artificial intelligence might be eating its software business today as it delivered a solid third-quarter earnings beat and lifted its revenue guidance for the fiscal year. The database and cloud infrastructure giant repo…
Domo shares rally 30% as earnings beat expectations despite modest revenue growth
Shares in Domo Inc. surged more than 30% in late trading today after the business intelligence and data visualization software company beat expectations for its fiscal 2026 fourth quarter. For the quarter that ended on Jan. 31, Domo reported adjusted earnings…
Marathon moves 298 BTC to Cumberland – Should Bitcoin traders worry?
MARA's $20M BTC transfer meets negative Funding Rates.
TrimX Drops Metabolism Claims Evaluated: Latest Report About TrimX Liquid Thermogenic Formula Ingredient Research & Effectiveness for Men & Women
TrimX Drops 2026 consumer report: metabolism claims, liquid thermogenic formula ingredients, pricing, and buyer verification checklist reviewed….
The Comeback of the Century: Wall Street Wrote Him Off…
But Elon’s $3 Trillion Comeback Could Begin Soon Elon Musk was declared washed up and finished. But any day now, he could unveil a new technology that outshines Tesla, SpaceX, even PayPal… a breakthrough big enough to solve America’s toughest problem, make President Trump a hero to the Western World… and spark a $3 trillion boom. Early investors could see massive gains. Details here.
🔍 Market Analysis & Insights
Oracle Will Downsize Its Product Teams Because Of AI
“AI is helping so much that we don't need people,” is the go-to narrative. But did Oracle convince investors?
Whispeara “6-Second Brain Mute Button” Claims Evaluated: 2026 Consumer Report Examining Whispeara Tinnitus Drops Ingredient Research for Natural Hearing Support
Whispeara “brain mute button” tinnitus claims examined. 2026 consumer report on ingredient research, neural signaling theory, and hearing support….
Sperm Health, Elon Musk, and Reddit Rabbit Holes—Welcome to the Bizarre World of Shilajit Supplements
A sticky black resinous material sourced from the Himalayas promises muscle-stacking, energy-stoking, health-enhancing benefits. The truth is even wilder.
Circle could rally 60% more on stablecoin adoption, AI agentic finance, Bernstein says
Stablecoins are decoupling from crypto market cycles as they are increasingly used for digital payments, Bernstein analysts said, which bodes well for USDC issuer Circle.
GameStop Shares Hold Steady Near $25 Amid Acquisition Speculation and Meme Stock Legacy
GameStop Corp. (NYSE: GME) shares traded in a narrow range around $24.80 in recent sessions, reflecting cautious investor sentiment as the video game retailer navigates ongoing speculation about a major acquisition under CEO Ryan Cohen while maintaining its s…
The Elon Musk “Mystery Metal” That Could Break China's Grip
Quietly engineered by Elon Musk… could end that crisis forever. And one tiny company is sitting at the center of it all. Musk is expected to make an announcement any day now. See more about this secret project here.
💰 Investment Opportunities
Bimzelx (UCB) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F
Opportunities in the Bimzelx market include expanding indications beyond psoriasis, increasing adoption of dual IL-17 inhibition therapies, enhanced personalized medicine options, and leveraging rising healthcare infrastructure investments. Growth in Asia-Pac…
Elrexfio (Pfizer: epcoritamab) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Key market opportunities for Elrexfio include rising adoption of immunotherapies, precision oncology, and bispecific antibodies. The growing incidence of multiple myeloma and healthcare expenditures drive demand. Asia-Pacific presents rapid growth potential, …
Ervebo (Merck & Co) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F
The Ervebo market is expanding due to heightened global pandemic preparedness, faster vaccine approvals, and increased healthcare investments. Opportunities include developing outbreak preparedness vaccines, expanding ring vaccination, and leveraging internat…
Feiba NF (Takeda Pharmaceuticals) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F
Key opportunities in the FEIBA NF market include the rising diagnosis and treatment of hemophilia, technological innovations in prophylaxis, expanding home infusion programs, increasing healthcare expenditure, and regional investments in plasma processing. Th…
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.
GARDEN CITY, N.Y., March 10, 2026 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of…
White House Insider Buck Sexton: “Trump's Next Move Will Shock the World”
It could dramatically increase U.S. power… and trigger a massive American market boom the likes of which we haven't seen in 75 years. Get the details here now.